Letter: Statins for Cirrhosis: Are we Ready to Move From Cardiovascular Prophylaxis to Portal Pressure Management? Authors' Reply

Documenti analoghi

• Statin Therapy Independently Reduces Mortality and Liver Complications in Patients With Cirrhosis: An Updated Systematic Review and Meta‐Analysis
  di: Bernardo de Faria Moraes, et al.
  Pubblicazione: (2026)
• Letter: Statins for Cirrhosis: Are We Ready to Move From Cardiovascular Prophylaxis to Portal Pressure Management?
  di: Abdulrahman Ismaiel
  Pubblicazione: (2026)
• Letter: The Unresolved Issue of NSBB Confounding in Statin Research for Cirrhosis
  di: Deliang Huang, et al.
  Pubblicazione: (2026)
• Letter: Amino Acid Imbalance and Mortality in Cirrhosis—Interpretation and Methodological Considerations. Authors' Reply
  di: Yuki Utakata, et al.
  Pubblicazione: (2026)
• Letter on: ‘Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS ’. Authors' Reply
  di: Christian Labenz, et al.
  Pubblicazione: (2026)